# Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

> **NCT03883776** · PHASE1 · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 12 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** Al18F-NOTA-octreotide
- **DEVICE:** PET/CT
- **OTHER:** Venous blood samples

## Key facts

- **NCT ID:** NCT03883776
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-11
- **Primary completion:** 2019-10-29
- **Final completion:** 2019-10-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883776, "Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03883776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*